Skip to main content

Text Size

  • Increase
  • Decrease

Current Size: 100%

Merck partners with Susan G. Komen for the Cure on historic initiative to help address cervical and breast cancer in developing nations

13 September 2011 – Merck announced today that it is contributing $3 million over three years to the Pink Ribbon–Red Ribbon initiative to help address both cervical and breast cancer in sub-Saharan African nations.

The initiative will support disease education, screening and treatment efforts as well as increased access to cervical cancer vaccination. This contribution is in addition to Merck's commitment to support a national cervical cancer vaccination program in Tanzania, which will soon be initiated by the Ministry of Health. Merck is a founding corporate partner of the Pink Ribbon–Red Ribbon initiative.